Crinetics Pharmaceuticals Ownership | Who Owns Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals Ownership Summary
Crinetics Pharmaceuticals is owned by 109.43% institutional investors, 1.98% insiders. Vanguard group is the largest institutional shareholder, holding 11.35% of CRNX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.19% of its assets in Crinetics Pharmaceuticals shares.
CRNX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Crinetics Pharmaceuticals | 109.43% | 1.98% | -11.41% |
| Sector | Healthcare Stocks | 279.18% | 10.62% | -189.80% |
| Industry | Biotech Stocks | 63.96% | 10.74% | 25.30% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Vanguard group | 9.09M | 11.35% | $464.74M |
| Fmr | 8.93M | 11.15% | $456.49M |
| Blackrock funding, inc. /de | 7.52M | 9.38% | $384.25M |
| Wellington management group llp | 6.95M | 8.68% | $355.38M |
| Blackrock | 6.23M | 8.62% | $279.06M |
| Driehaus capital management | 6.14M | 7.67% | $313.99M |
| Price t rowe associates inc /md/ | 5.41M | 6.76% | $276.84M |
| Ecor1 capital | 4.29M | 5.35% | $219.25M |
| Farallon capital management | 4.08M | 5.09% | $208.36M |
| State street | 2.99M | 3.73% | $152.92M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| New leaf venture partners | 141.00K | 9.64% | $7.21M |
| Ecor1 capital | 4.29M | 8.29% | $219.25M |
| Bioimpact capital | 617.03K | 4.48% | $31.55M |
| First light asset management | 885.45K | 4.33% | $45.27M |
| Siren | 1.61M | 3.64% | $82.30M |
| Ikarian capital | 516.43K | 3.59% | $26.41M |
| Paradigm biocapital advisors lp | 1.91M | 3.40% | $97.70M |
| Ghost tree capital | 240.00K | 3.37% | $10.75M |
| Affinity asset advisors | 460.00K | 3.15% | $23.52M |
| Novo | 960.22K | 2.97% | $49.10M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Fmr | 8.93M | 0.03% | 4.47M |
| Farallon capital management | 4.08M | 1.06% | 2.91M |
| Vanguard group | 9.09M | 0.01% | 2.80M |
| Wellington management group llp | 6.95M | 0.07% | 2.49M |
| Blackrock funding, inc. /de | 7.52M | 0.01% | 965.25K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Lord, abbett | - | - | -724.63K |
| Eventide asset management | - | - | -609.01K |
| Paradigm biocapital advisors lp | 1.91M | 3.40% | -605.92K |
| First turn management | - | - | -453.38K |
| Dimensional fund advisors lp | - | - | -392.20K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Segall bryant & hamill | 150.40K | 0.11% | 150.40K | $7.69M |
| Schroder investment management group | 29.36K | 0.00% | 29.36K | $1.49M |
| Pathstone | 20.43K | 0.00% | 20.43K | $1.04M |
| Skandinaviska enskilda banken ab (publ) | 18.12K | 0.00% | 18.12K | $917.99K |
| Verition fund management | 17.22K | 0.00% | 17.22K | $880.30K |
Sold Out
| Holder | Change |
|---|---|
| Capital performance advisors llp | -8.00 |
| Cibc private wealth group | -15.00 |
| Northwestern mutual wealth management | -16.00 |
| Householder group estate & retirement specialist | -25.00 |
| Newedge advisors | -30.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 227 | -8.84% | 101,882,125 | 2.21% | 109 | 0.71% | 125 | -15.54% | 72 | 9.09% |
| Dec 31, 2024 | 243 | 2.53% | 99,207,040 | 17.39% | 123 | 1.11% | 144 | 18.03% | 66 | -12.00% |
| Sep 30, 2024 | 235 | -1.67% | 84,500,757 | 2.47% | 105 | 0.81% | 121 | -20.91% | 74 | 37.04% |
| Jun 30, 2024 | 239 | 8.64% | 82,467,822 | 2.56% | 114 | 0.92% | 153 | 20.47% | 54 | -3.57% |
| Mar 31, 2024 | 220 | 11.68% | 80,408,468 | 13.80% | 111 | 0.75% | 127 | 13.39% | 56 | - |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 2.99M | 3.19% | 11.40K |
| Vanguard US Total Market Shares ETF | 2.40M | 2.58% | 2.45K |
| iShares Russell 2000 ETF | 2.34M | 2.50% | 1.15K |
| Vanguard Small Cap Index | 2.33M | 2.49% | 11.78K |
| Vanguard Health Care Inv | 2.28M | 2.44% | - |
| US Small-Cap Growth II Equity Comp | 2.11M | 2.27% | -29.22K |
| T. Rowe Price New Horizons | 2.11M | 2.27% | -28.60K |
| Fidelity OTC | 1.66M | 1.77% | 1.66M |
| Vanguard Institutional Extnd Mkt Idx Tr | 1.43M | 1.53% | 5.62K |
| Vanguard Small Cap Growth Index Inv | 1.30M | 1.39% | -977.00 |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Mar 19, 2025 | Pizzuti Dana | Chief Med and Dev Officer | Sell | $4.42K |
| Mar 19, 2025 | Pizzuti Dana | Chief Med and Dev Officer | Sell | $81.60K |
| Mar 19, 2025 | Knight Jeff E. | Chief Operating Officer | Sell | $232.39K |
| Mar 19, 2025 | Knight Jeff E. | Chief Operating Officer | Sell | $12.57K |
| Mar 19, 2025 | Betz Stephen F. | Chief Scientific Officer | Sell | $187.22K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | - | - |
| 2025 Q1 | - | 10 |
| 2024 Q4 | - | 3 |
| 2024 Q3 | - | 11 |
| 2024 Q2 | - | 11 |
CRNX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools